Propel Bio Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Propel Bio Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$8.85M	Sell
2025 Q1	$7.12M	Buy
2024 Q4	$8.04M	Buy
2024 Q3	$15.7M	Hold
2024 Q2	$8.96M	Hold
2024 Q1	$9.24M	Buy
2023 Q4	$4.05M	Buy